Market Opportunity : Major opportunities include oral GLP-1 innovations, combination therapies integrating GIP/GLP-1 pathways, improved affordability for emerging markets, expanding indications beyond diabetes and obesity, and partnerships to enhance manufacturing capacity, distribution, and long-term patient adherence
IDUNs product is sold as a research reference compound and is not a drug, dietary supplement, food, or cosmetic
Novo Nordisk sued Eli Lilly for allegedly running a deceptive ad campaign that uses outdated clinical trials to make its obesity and diabetes drugs appear more effective, marking a new phase in one of the pharmaceutical industrys most intense rivalries
Glutathione, which is often called the bodys superhero, is a powerful antioxidant that plays a vital role in keeping our cells healthy